Healthway Medical reviews Lippo's loan, Gateway's proposal
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
HEALTHWAY Medical Corp (HMC) is reviewing the brief non-binding terms of a S$10 million loan by Lippo China Resources (LCR) to pay doctors and nurses, as well as an alternate proposal by Gateway Partners.
The private clinic operator said in a Singapore Exchange filing after the market closed on Monday that it has received non-binding terms for the proposed interim financing from LCR.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Air India asks Tata, Singapore Airlines for funds after US$2.4 billion loss
‘Boring’ is the new black: The stars are aligning for a Singapore stock market revival
From 1MDB to ‘corporate mafia’: Is Malaysia facing a new governance test?
South-east Asian markets account for 8.8% of global capital inflows from 2021 to 2024: report